Laser induced autofluorescence diagnosis of bladder cancer

Journal of Urology

Volumn 156, Issue 5, 1996, Pages 1597-1601

  Koenig, Frank ^a   Mcgovern, Francis J ^b   Althausen, Alex F ^b   Deutsch, Thomas F ^b   Schomacker, Kevin T ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

bladder neoplasms; diagnosis; fluorescence; lasers

Indexed keywords

BCG VACCINE;

ADULT; AGED; ALGORITHM; ARTICLE; AUTOFLUORESCENCE; BLADDER BIOPSY; BLADDER CANCER; BLADDER TUMOR; CANCER RADIOTHERAPY; CLINICAL FEATURE; CYSTOSCOPY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FEMALE; FLUORESCENCE SPECTROSCOPY; HISTOLOGY; HUMAN; HUMAN TISSUE; LASER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSURETHRAL RESECTION;

EID: 0029951201     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65456-9     Document Type: Article

References (23)

1. American Cancer Society: Cancer Facts & Figures-1995. Atlanta: American Cancer Society, Inc., 1995.
2. Greene, L. F., Hanash, K. A. and Farrow, G. M.: Benign papilloma or papillary carcinoma of the bladder? J. Urol., 110: 205, 1973.
3. Kiemeney, L. A. L. M., Witjes, J. A., Heijbroek, R. P., Verbeek, A. L. M. and Debruyne, F. M. J.: Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer. J. Urol., 150: 60, 1993.
4. Heney, N. M., Ahmed, S., Flanagan, M. J., Frable, W., Corder, M. P., Hafermann, M. D. and Hawkins, I. R. for National Bladder Cancer Collaborative Group A: Superficial bladder cancer: progression and recurrence. J. Urol., 130: 1083, 1983.
5. Althausen, A. F., Prout, G. P., Jr. and Daly, J. J.: Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. J. Urol., 116: 575, 1976.
6. Wolf, H., Olsen, P. R., Fischer, A. and Højgaard, K.: Urothelial atypia concomitant with primary bladder tumour. Incidence in a consecutive series of 500 unselected patients. Scand. J. Urol. Nephrol., 21: 33, 1987.
7. Kriegmair, M., Baumgartner, R., Knüchel, R., Stepp, H., Hofstädter, F. and Hofstetter, A.: Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J. Urol., 155: 105, 1996.
8. Jichlinski, P., Mizeret, J., Forrer, M., Wagniere, G., Van den Bergh, H., Schmidlin, F., Graber, P. and Leisinger, H. J.: Superficial bladder tumors. Pathological and clinical review and presentation of a new diagnostic method: fluorescence photodetection of transitional epithelial carcinomas based on protoporphyrin IX induction with delta-aminolevulinic acid (5-ALA). Rev. Med. Suisse Romande, 115: 233, 1995.
9. Mourant, J. R., Bigio, I. J., Boyer, J., Conn, R. L., Johnson, T. and Shimada, T.: Spectroscopic diagnosis of bladder cancer with elastic light scattering. Lasers Surg. Med., 17: 350, 1995.
10. Schomacker, K. T., Flotte, T. J. and Deutsch, T. F.: Detection of chemically-induced dysplasia in rat urinary bladder with laser-induced fluorescence. In: Advances in Laser and Light Spectroscopy to Diagnose Cancer and Other Diseases. Edited by R. R. Alfano. Proc. SPIE, vol. 2135, pp. 76-79, 1994.
11. D'Hallewin, M. A., Baert, L. and Vanherzeele, H.: Fluorescence imaging of bladder cancer. Acta Urol. Belg., 62: 49, 1994.
12. Baert, L., Berg, R., Van Damme, B., D'Hallewin, M. A., Johansson, J., Svanberg, K. and Svanberg, S.: Clinical fluorescence diagnosis of human bladder carcinoma following lowdose Photofrin injection. Urology, 41: 322, 1993.
13. Campbell, M. J. and Machin, D.: Probability and decision making: diagnostic tests. In: Medical Statistics, 2nd ed. New York: John Wiley & Sons, vol. 2, chapt. 3.2, pp. 34-35, 1993.
14. Lam, S., MacAulay, C., Hung, J., LeRiche, J., Profio, A. E. and Palcic, B.: Detection of dysplasia and carcinoma in situ with a lung imaging fluorescence endoscope device. J. Thorac. Cardiovasc. Surg., 105: 1035, 1993.
15. Schomacker, K. T., Frisoli, J. K., Compton, C. C., Flotte, T. J., Richter, J. M., Nishioka, N. S. and Deutsch, T. F.: Ultraviolet laser-induced fluorescence of colonic tissue: basic biology and diagnostic potential. Lasers Surg. Med., 12: 63, 1992.
16. Ramanujam, N., Mitchell, M. F., Mahadevan, A., Thomsen, S., Silva, E. and Richards-Kortum, R.: Fluorescence spectroscopy: a diagnostic tool for cervical intraepithelial neoplasia (CIN). Gynec. Oncol., 52: 31, 1994.
17. Fink, F., Paul, R. and Pfarrherr, A.: Laser fluorescence spectroscopic experiments for monitoring molecules in brain. Adv. Exp. Med. Biol., 333: 233, 1993.
18. Boulnois, J.-L.: Photophysical processes in recent medical laser developments: a review. Laser Med. Sci., 1: 47, 1986.
19. Young, R. H.: Non-neoplastic epithelial abnormalities and tumor-like lesions. In: Pathology of the Urinary Bladder. Edited by L. M. Roth. New York: Churchill Livingstone, vol. 13, pp. 1-55, 1989.
20. Romanenko, A. M. and Mirgorodskaia, L. N.: Histochemical characteristics of oxidation-reduction enzymes in epithelial tumors of the urinary bladder. Vopr. Onkol., 17: 43, 1971.
21. Vanderlaan, M., Fong, S. and King, E. B.: Histochemistry of NADH diaphorase and gamma-glutamyltranspeptidase in rat bladder tumors. Carcinogenesis, 3: 397, 1982.
22. Daly, J. J.: Carcinoma-in-situ of the urothelium. Urol. Clin. N. Amer., 3: 87, 1976.
23. Hudson, M. A. and Herr, H. W.: Carcinoma in situ of the bladder. J. Urol., 153: 564, 1995.